Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zeprumetostat in R/R Follicular Lymphoma
NCT06368167Phase 2Not yet recruiting
- Sponsor
- Hengrui
- Start
- Apr 2024
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zeprumetostat in follicular lymphoma (FL), sponsored by Hengrui. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
zeprumetostat
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT06368167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06368167.